Dec 18 (Reuters) - Novavax Inc NVAX.O:
NOVAVAX INC - ON DEC 12, ENTERED AMENDMENT 5 TO ADVANCED PURCHASE AGREEMENT WITH COMMONWEALTH OF AUSTRALIA
NOVAVAX- ACKNOWLEDGED COMMONWEALTH CANCELLATION OF DELIVERING CERTAIN DOSES OF CO’S COVID-19 VACCINE SCHEDULED FOR DELIVERY BETWEEN Q4 2023 & Q4 2025
NOVAVAX- AGREED TO UPDATED DELIVERY SCHEDULE FOR POTENTIAL DELIVERY OF COVID-19 VACCINE/FUTURE VARIANT COVID-19 VACCINE THROUGH END OF 2029
Source text: [ID:n0001104659-24-129823]
Further company coverage: NVAX.O
((Reuters.Briefs@thomsonreuters.com;))